Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:MAXNASDAQ:OABINASDAQ:TRMRNASDAQ:UXIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMAXMediaAlpha$10.95-1.5%$9.49$7.33▼$20.91$745.37M1.19617,669 shs545,432 shsOABIOmniAb$1.78+4.1%$1.62$1.22▼$4.96$217.40M-0.03666,087 shs868,307 shsTRMRTremor International$9.95$3.15▼$8.59$726.18M1.9232,483 shs49,946 shsUXINUxin$3.71-7.0%$4.30$1.41▼$7.84$697.43M1.31530,114 shs56,341 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMAXMediaAlpha0.00%+3.61%+3.60%+17.82%-37.93%OABIOmniAb0.00%+18.67%+14.84%-46.22%-59.55%TRMRTremor International0.00%0.00%0.00%0.00%+55.88%UXINUxin0.00%-0.80%-18.46%-11.46%+64.89%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMAXMediaAlpha4.2657 of 5 stars4.44.00.00.02.62.51.9OABIOmniAb3.1174 of 5 stars3.51.00.00.03.33.31.3TRMRTremor InternationalN/AN/AN/AN/AN/AN/AN/AN/AUXINUxin0.5661 of 5 stars0.03.00.00.02.31.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMAXMediaAlpha 2.86Moderate Buy$17.2157.21% UpsideOABIOmniAb 3.00Buy$7.00293.26% UpsideTRMRTremor International 0.00N/AN/AN/AUXINUxin 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest OABI, TRMR, MAX, and UXIN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2025OABIOmniAbBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.005/7/2025MAXMediaAlphaRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$20.00 ➝ $18.005/1/2025MAXMediaAlphaJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$10.00 ➝ $12.004/22/2025MAXMediaAlphaJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$13.00 ➝ $10.004/22/2025MAXMediaAlphaKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$19.00 ➝ $16.004/14/2025MAXMediaAlphaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $12.504/3/2025MAXMediaAlphaBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$27.00 ➝ $23.003/27/2025OABIOmniAbRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$7.00 ➝ $4.003/20/2025OABIOmniAbBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $6.003/19/2025OABIOmniAbHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$11.00 ➝ $11.00(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMAXMediaAlpha$1.00B0.73N/AN/A($1.44) per share-7.60OABIOmniAb$26.74M8.13N/AN/A$2.69 per share0.66TRMRTremor International$343.77M0.00N/A3.98$7.67 per share0.00UXINUxin$1.63B0.43$1.06 per share3.50($0.22) per share-16.86Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMAXMediaAlpha-$40.42M$0.2864.4112.73N/A1.41%-11.98%5.19%7/30/2025 (Estimated)OABIOmniAb-$50.62M-$0.58N/AN/AN/A-308.78%-20.97%-18.05%8/6/2025 (Estimated)TRMRTremor International$22.74M-$0.14N/A0.00N/A-5.72%3.11%1.89%N/AUXINUxin-$51.58M-$18.08N/A∞N/A-20.57%-248.43%73.24%6/30/2025 (Estimated)Latest OABI, TRMR, MAX, and UXIN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2025Q4 2025UXINUxinN/A-$0.03N/A-$0.04N/A$69.48 million5/8/2025Q1 2025OABIOmniAb-$0.17-$0.17N/A-$0.17$4.49 million$4.15 million4/30/2025Q1 2025MAXMediaAlpha$0.17$0.15-$0.02-$0.04$236.07 million$264.31 million4/30/2025Q4 2025UXINUxinN/A-$0.03N/A-$0.07N/A$81.76 million3/18/2025Q4 2024OABIOmniAb-$0.13-$0.12+$0.01-$0.12$10.13 million$10.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMAXMediaAlphaN/AN/AN/AN/AN/AOABIOmniAbN/AN/AN/AN/AN/ATRMRTremor InternationalN/AN/AN/AN/AN/AUXINUxinN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMAXMediaAlphaN/A1.221.22OABIOmniAbN/A4.624.62TRMRTremor International0.232.052.05UXINUxinN/A0.440.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMAXMediaAlpha64.39%OABIOmniAb72.08%TRMRTremor International7.88%UXINUxin22.41%Insider OwnershipCompanyInsider OwnershipMAXMediaAlpha13.44%OABIOmniAb8.60%TRMRTremor International8.20%UXINUxin62.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMAXMediaAlpha16067.03 million58.98 millionNot OptionableOABIOmniAb7122.14 million129.07 millionOptionableTRMRTremor International16772.62 millionN/ANot OptionableUXINUxin810187.99 million69.68 millionOptionableOABI, TRMR, MAX, and UXIN HeadlinesRecent News About These CompaniesMillennium Management LLC Sells 70,919 Shares of Uxin Limited (NASDAQ:UXIN)June 14 at 3:11 AM | marketbeat.comUxin Limited (UXIN) First Quarter 2025 Earnings Call TranscriptJune 13 at 6:09 PM | seekingalpha.comWhy Uxin Stock Was Crushing It This WeekJune 13 at 6:09 PM | finance.yahoo.comUxin Limited Reports Strong Year-Over-Year GrowthJune 12 at 11:59 PM | tipranks.comUxin (NASDAQ:UXIN) Shares Down 7.8% - What's Next?June 12 at 1:20 PM | marketbeat.comUxin (NASDAQ:UXIN) Posts Quarterly Earnings ResultsJune 12 at 9:47 AM | marketbeat.comUxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2025June 12 at 5:01 AM | prnewswire.comUxin (NASDAQ:UXIN) Sees Strong Trading Volume - Should You Buy?June 11, 2025 | marketbeat.comUxin (NASDAQ:UXIN) Shares Gap Up - Should You Buy?June 10, 2025 | marketbeat.comUxin (NASDAQ:UXIN) Trading 7.4% Higher - Should You Buy?June 9, 2025 | marketbeat.comUxin (NASDAQ:UXIN) & Heritage Global (NASDAQ:HGBL) Financial ReviewJune 9, 2025 | americanbankingnews.comUxin to Report First Quarter 2025 Financial Results on June 12, 2025June 6, 2025 | prnewswire.comUxin Limited (NASDAQ:UXIN) Sees Large Decline in Short InterestJune 4, 2025 | marketbeat.comUxin (NASDAQ:UXIN) Shares Gap Up - Here's WhyJune 3, 2025 | marketbeat.comUxin (NASDAQ:UXIN) Shares Gap Up - Still a Buy?May 23, 2025 | marketbeat.comA plant hormone's secret passage: Researchers elucidate molecular mechanism of auxin influxMay 15, 2025 | msn.comUxin (NASDAQ:UXIN) Trading Up 6.1% - What's Next?May 15, 2025 | marketbeat.comUxin Full Year 2024 Earnings: CN¥2.39 loss per share (vs CN¥64.67 loss in FY 2023)May 2, 2025 | finance.yahoo.comUxin Ltd (UXIN) Q4 2024 Earnings Call Highlights: Record Growth and Positive EBITDA Mark a ...May 1, 2025 | finance.yahoo.comUxin Limited (UXIN) Fourth Quarter And Full Year 2024 Earnings Conference Call TranscriptApril 30, 2025 | seekingalpha.comUxin Reports Strong Growth and Expansion Plans Amidst Economic ChallengesApril 30, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOABI, TRMR, MAX, and UXIN Company DescriptionsMediaAlpha NYSE:MAX$10.95 -0.17 (-1.53%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$10.98 +0.03 (+0.27%) As of 06/13/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MediaAlpha, Inc., through its subsidiaries, operates an insurance customer acquisition platform in the United States. It optimizes customer acquisition in various verticals of property and casualty insurance, health insurance, and life insurance. The company was founded in 2014 and is headquartered in Los Angeles, California.OmniAb NASDAQ:OABI$1.78 +0.07 (+4.09%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.79 +0.01 (+0.56%) As of 06/13/2025 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.Tremor International NASDAQ:TRMRTremor International Ltd provides end-to-end software platform that enables advertisers to reach relevant audiences and publishers. The company's demand side platform (DSP) offers full-service and self-managed marketplace access to advertisers and agencies to execute their digital marketing campaigns in real time across various ad formats. Its sell supply side platform (SSP) provides access to data and a comprehensive product suite to drive inventory management and revenue optimization. The company also offers data management platform solution, which integrates DSP and SSP solutions enabling advertisers and publishers to use data from various sources in order to optimize results of their advertising campaigns. It serves ad buyers, advertisers, brands, agencies, and digital publishers in Israel, the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company was formerly known as Taptica International Ltd. and changed its name to Tremor International Ltd in September 2015. Tremor International Ltd was incorporated in 2007 and is headquartered in Tel Aviv-Yafo, Israel.Uxin NASDAQ:UXIN$3.71 -0.28 (-7.02%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$3.77 +0.06 (+1.62%) As of 06/13/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Uxin Limited, an investment holding company, engages in the retail sale of vehicles in China. The company operates an e-commerce platform for buying and selling used cars. It also offers used-car acquisition, inspection, reconditioning, warehousing, pre-sales and after-sales, and various car-related value-added products and services, as well as warranty and repair, delivery, and title transfers and vehicle registration services. Uxin Limited was incorporated in 2011 and is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
